Lantern Pharma (LTRN)

• Market cap: $36.9M
• 1 day: -2.01%
• 5 days: 12.13%
• 1 month: -12.98%
• 3 months: -7.32%
• 6 months: 0.88%
• Year to date: 3.64%
• 1 year: -42.90%
• 5 years: -77.12%
• 10 years: -77.12%
• Sector: Healthcare
• Industry: Biotechnology

About: Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

Employees: 24

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

700% more call options, than puts

Call options by funds: $16K | Put options by funds: $2K

63% more capital invested

Capital invested by funds: $4.9M [Q3] → $8M (+$3.09M) [Q4]

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

10.76% more ownership

Funds ownership: 12.4% [Q3] → 23.17% (+10.76%) [Q4]

3% more funds holding

Funds holding: 31 [Q3] → 32 (+1) [Q4]

20% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 10

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $25 631% upside
• Avg. target: $25 631% upside
• High target: $25 631% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Lake Street Chad Messer 67% 1-year accuracy 2 / 3 met price target

631% upside $25

Buy Initiated

2 Apr 2025